Central serous chorioretinopathy in a COVID-19-positive patient with torpedo maculopathy and associated oral tadalafil intake

Abstract

A 46-year-old post-COVID-19-positive male patient presented with sudden onset painless loss of vision in the left eye (LE). There was history of oral tadalafil intake 10 days before vision loss. Clinical and imaging examinations led to the diagnosis of central serous chorioretinopathy with torpedo maculopathy in LE. No active intervention was done. There was complete resolution of neurosensory detachment with improvement of vision 1 month following the presentation.

Keywords

• central serous chorioretinopathy
• covid-19
• tadalafil
• torpedo maculopathy